Literature DB >> 24057292

An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.

Sabine E Hannema1, Hermine A van Duyvenvoorde, Thomas Premsler, Ruey-Bing Yang, Thomas D Mueller, Birgit Gassner, Heike Oberwinkler, Ferdinand Roelfsema, Gijs W E Santen, Timothy Prickett, Sarina G Kant, Annemieke J M H Verkerk, André G Uitterlinden, Eric Espiner, Claudia A L Ruivenkamp, Wilma Oostdijk, Alberto M Pereira, Monique Losekoot, Michaela Kuhn, Jan M Wit.   

Abstract

BACKGROUND: C-type natriuretic peptide (CNP)/natriuretic peptide receptor 2 (NPR2) signaling is essential for long bone growth. Enhanced CNP production caused by chromosomal translocations results in tall stature, a Marfanoid phenotype, and skeletal abnormalities. A similar phenotype was described in a family with an activating NPR2 mutation within the guanylyl cyclase domain. CASE: Here we describe an extremely tall male without skeletal deformities, with a novel NPR2 mutation (p.Arg655Cys) located in the kinase homology domain.
OBJECTIVES: The objective of the study was to investigate the functional and structural effects of the NPR2 mutation.
METHODS: Guanylyl cyclase activities of wild-type vs mutant NPR2 were analyzed in transfected human embryonic kidney 293 cells and in skin fibroblasts. The former were also used to study possible interactions between both isoforms. Homology modeling was performed to understand the molecular impact of the mutation.
RESULTS: CNP-stimulated cGMP production by the mutant NPR2 was markedly increased in patient skin fibroblasts and transfected human embryonic kidney 293 cells. The stimulatory effects of ATP on CNP-dependent guanylyl cyclase activity were augmented, suggesting that this novel mutation enhances both the responsiveness of NPR2 to CNP and its allosteric modulation/stabilization by ATP. Coimmunoprecipitation showed that wild-type and mutant NPR2 can form stable heterodimers, suggesting a dominant-positive effect. In accordance with augmented endogenous receptor activity, plasma N-terminal pro-CNP (a marker of CNP production in tissues) was reduced in the proband.
CONCLUSIONS: We report the first activating mutation within the kinase homology domain of NPR2, resulting in extremely tall stature. Our observations emphasize the important role of this domain in the regulation of guanylyl cyclase activity and bone growth in response to CNP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057292     DOI: 10.1210/jc.2013-2358

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

Review 1.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

Review 2.  Short and tall stature: a new paradigm emerges.

Authors:  Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

3.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

4.  Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats.

Authors:  Luqiang Wang; Haoruo Jia; Robert J Tower; Michael A Levine; Ling Qin
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-19       Impact factor: 4.310

5.  cGMP-dependent protein kinase-2 regulates bone mass and prevents diabetic bone loss.

Authors:  Ghania Ramdani; Nadine Schall; Hema Kalyanaraman; Nisreen Wahwah; Sahar Moheize; Jenna J Lee; Robert L Sah; Alexander Pfeifer; Darren E Casteel; Renate B Pilz
Journal:  J Endocrinol       Date:  2018-06-18       Impact factor: 4.286

6.  Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.

Authors:  Sophie R Wang; Christina M Jacobsen; Heather Carmichael; Aaron B Edmund; Jerid W Robinson; Robert C Olney; Timothy C Miller; Jennifer E Moon; Veronica Mericq; Lincoln R Potter; Matthew L Warman; Joel N Hirschhorn; Andrew Dauber
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

7.  Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.

Authors:  Eveline Boudin; Tjeerd R de Jong; Tim C R Prickett; Bruno Lapauw; Kaatje Toye; Viviane Van Hoof; Ilse Luyckx; Aline Verstraeten; Hugo S A Heymans; Eelco Dulfer; Lut Van Laer; Ian R Berry; Angus Dobbie; Ed Blair; Bart Loeys; Eric A Espiner; Jan M Wit; Wim Van Hul; Peter Houpt; Geert R Mortier
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

Review 8.  Recent research on the growth plate: Recent insights into the regulation of the growth plate.

Authors:  Julian C Lui; Ola Nilsson; Jeffrey Baron
Journal:  J Mol Endocrinol       Date:  2014-04-16       Impact factor: 5.098

9.  The Biology of Stature.

Authors:  Youn Hee Jee; Jeffrey Baron
Journal:  J Pediatr       Date:  2016-03-26       Impact factor: 4.406

Review 10.  Intraovarian control of early folliculogenesis.

Authors:  Aaron J W Hsueh; Kazuhiro Kawamura; Yuan Cheng; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.